BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16934338)

  • 1. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
    Antel J; Bar-Or A
    J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.
    Obermeier B; Mentele R; Malotka J; Kellermann J; Kümpfel T; Wekerle H; Lottspeich F; Hohlfeld R; Dornmair K
    Nat Med; 2008 Jun; 14(6):688-93. PubMed ID: 18488038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid analysis in multiple sclerosis.
    Luque FA; Jaffe SL
    Int Rev Neurobiol; 2007; 79():341-56. PubMed ID: 17531849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.
    Roström B; Link H; Laurenzi MA; Kam-Hansen S; Norrby E; Wahren B
    Ann Neurol; 1981 Jun; 9(6):569-74. PubMed ID: 7259119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.
    LaGanke CC; Freeman DW; Whitaker JN
    Ann Neurol; 2000 Jan; 47(1):87-92. PubMed ID: 10632105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
    Archelos JJ; Trotter J; Previtali S; Weissbrich B; Toyka KV; Hartung HP
    Ann Neurol; 1998 Jan; 43(1):15-24. PubMed ID: 9450764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.
    Mehling M; Kuhle J; Regeniter A
    Neurologist; 2008 Jan; 14(1):60-5. PubMed ID: 18195662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress of research in the diagnosis of multiple sclerosis by study of the cerebrospinal fluid].
    Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
    Psychiatr Neurol Med Psychol (Leipz); 1987 Nov; 39(11):651-61. PubMed ID: 2450384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
    Meinl E; Krumbholz M; Hohlfeld R
    Ann Neurol; 2006 Jun; 59(6):880-92. PubMed ID: 16718690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
    Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
    Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrospinal fluid in multiple sclerosis].
    Mitsui T; Ohno R
    Nihon Rinsho; 2003 Aug; 61(8):1335-9. PubMed ID: 12962020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: multiple sclerosis cerebrospinal fluid IgG multiple bands are derived from one or a few IgG secretor cell clones.
    Tourtellotte WW; Shapshak P; Staugaitis SM; Saxton RE
    Prog Clin Biol Res; 1984; 146():371-8. PubMed ID: 6718429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Binding of immunoglobulins of the cerebrospinal fluid of multiple sclerosis patients to oligodendrocytes in culture].
    Lubetzki C; Lombrail P; Hauw JJ; Baumann N; Zalc B
    Pathol Biol (Paris); 1987 Mar; 35(3):314-8. PubMed ID: 3295697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
    Villar L; García-Barragán N; Espiño M; Roldán E; Sádaba M; Gómez-Rial J; González-Porqué P; Alvarez-Cermeño J
    Mult Scler; 2008 Mar; 14(2):183-7. PubMed ID: 17942517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.